Abstract: Background: Urethral discharge syndrome (UDS) is characterized by the presence of purulent or mucopurulent urethral discharge.The main etiological agents of this syndrome are Neisseria gonorrhoeae and Chlamydia trachomatis. oBjectives: To evaluate the effectiveness of the syndromic management to resolve symptoms in male urethral discharge syndrome cases in Manaus, Amazonas, Brazil. Methods: Retrospective cohort of male cases of urethral discharge syndrome observed at a clinic for sexually transmitted disease (STD) in 2013. Epidemiological and clinical data, as well as the results of urethral swabs, bacterioscopy, hybrid capture for C.trachomatis, wet-mount examination, and culture for N.gonorrhoeae, were obtained through medical chart reviews. results: Of the 800 urethral discharge syndrome cases observed at the STD clinic, 785 (98.1%) presented only urethral discharge syndrome, 633 (79.1%) returned for follow-up, 579 (91.5%) were considered clinically cured on the first visit, 41(6.5 %) were considered cured on the second visit, and 13(2.0%) did not reach clinical cure after two appointments. Regarding the etiological diagnosis, 42.7% of the patients presented a microbiological diagnosis of N.gonorrhoeae, 39.3% of non-gonococcal and non-chlamydia urethritis, 10.7% of C.trachomatis and 7.3% of co-infection with chlamydia and gonococcus. The odds of being considered cured in the first visit were greater in those who were unmarried, with greater schooling, and with an etiological diagnosis of gonorrhea. The diagnosis of non-gonococcal urethritis reduced the chance of cure in the first visit. study liMitation: A study conducted at a single center of STD treatment. conclusion: Syndromic management of male urethral discharge syndrome performed in accordance with the Brazilian Ministry of Health STD guidelines was effective in resolving symptoms in the studied population. More studies with microbiological outcomes are needed to ensure the maintenance of the syndromic management.
INTRODUCTION
Urethral discharge syndrome (UDS) is characterized by the presence of purulent urethral discharge or mucopurulent urethral discharge associated with dysuria, pain when urinating, itching, and foul odor. The main etiological agents of this syndrome are Neisseria gonorrhoeae and Chlamydia trachomatis.¹ Possible complications of gonococcal urethritis (GU) are locally invasive disease, urethral stenosis, and disseminated gonococcal infection. Non-gonococcal urethritis is usually self-limited, and may cause epididymitis and occasionally conjunctivitis, as well as reactive arthritis. However, with the advent of antibiotics, these complications have become rare.² In 2005, the World Health Organization (WHO) estimated that, in the Americas, the number of cases of men with C. trachomatis infection was 7.98 per million as compared to 1.56 per million cases of N. gonorrhoeae. 3 In 2008, the same organization estimated that, globally, there would be more than 498.9 million new cases of curable sexually transmitted disease (STD) (syphilis, gonorrhea, chlamydia, and trichomoniasis) in adults of 15-45 years of age. 4 In Ethiopia, a urethral discharge rate of 13.6% was found. 5 In Peru, 15.4%
of men who had sex with men were infected with curable STD, and 5.5% presented urethral discharge. 6 In Brazil, according to the Brazilian Ministry of Health, UDS is responsible for approximately 15% of STD
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. A study in six Brazilian capital cities identified a prevalence of gonorrhea of 0.9% and 3.4% of chlamydia in males. In this study, the Manaus male population presented 3.0% of chlamydia and 1.3% of gonorrhea prevalence. 7 Another study in the northeast region of Brazil verified a 5.2%
prevalence of UDS. 8 Barbosa et al. (2010) , also in Brazil, found a 13.1% prevalence of Chlamydia trachomatis and an 18.4% prevalence of Neisseria gonorrhoeae among 767 subjects, of whom 92.9% were men. 9 One of the measures adopted to control STD is syndromic management (SM), whose use was established in the early 1990s.
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In Brazil, these measures were implemented in 1993, 11 but the algorithms were only recognized in 1998. 12 This indirect approach to STD is based on the identification of consistent groups of symptoms and easily recognized signs (syndromes), providing treatment that will cover the majority or most serious organisms responsible for the syndrome. In 1998, an Indonesian study on SM predicted that this approach would have a great impact on the control and prevention of STD and AIDS in both sexes. 13 Van Dam et al. reported that, in the absence of diagnostic tests for STD etiological agents, SM was effective and appropriate for treating patients with STD. 14 In Canada, SM has been established as a standard diagnostic and therapeutical approach for patients within high-risk groups, as it was considered cheap, simple, and accurate for the management of STD. 15 In China and in the USA, SM was considered relatively adequate and effective for the clinical application in UDS. 16, 17 In Italy, SM for urethral discharge had effective treatment results in the first appointment. 18 The city of Manaus, Amazonas, has a tertiary health service, which is a reference center for the diagnosis and treatment of STD in Brazil, handling an average of 1,000 UDS cases per year.
This study aimed to evaluate the effectiveness of SM of male UDS cases, as proposed by the Brazilian Ministry of Health, using the resolution of symptoms on the first and second follow-up visits after SM as the outcome. In addition, we described the clinical and epidemiological profile of the population studied, as well as the etiological results of UDS. The presence of mucopurulent or purulent urethral discharge was confirmed by checking the retracted foreskin or after compressing the base of the penis towards the glans, as described elsewhere. 19 Patients were then prescribed first-line drugs recommended by the Brazilian Ministry of Health STD guidelines. 
METHODS

RESULTS
Of the 800 UDS cases observed at the STD clinic in 2013, (Table 4) .
DISCUSSION
This study aimed to investigate the effectiveness of SM in male patients with UDS who received medical care at an STD clinic in the city of Manaus. The average age of the studied population is consistent with other epidemiological studies of STD worldwide and in Brazil, whose reported average age ranged from 15 to 49 years of age. The unmarried marital status, prevalent in this study, is also the most reported by other authors. 4, 20 Approximately one third of men with UDS included in the study reported having more than three casual sex partners. A study carried out in Kisumu, Kenya, reported that 61.2% of men with UDS were single and 53% had more than four sex partners. 21 Regarding education, in this study 65.7% reported having more than 8 years of schooling. A study conducted in the northeast of Brazil showed that only 12.9% of patients with UDS had studied for over 8 years. 9 Despite the apparent higher education reported in this study, condom use was reported as occasional in most cases (59.4%) and, among those who did not return after the first visit, the scenario was even worse (67.1%). This suggests that this population either had limited access to condoms and/or that sexual education or the already established health policies in place are not reaching this group, leading to an increase in the incidence of STD and their complications.
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In this study, most cases (70.9%) sought care directly at the FUAM STD clinic without referral, despite the fact that this clinic is considered of tertiary complexity, but delivers easy access to trained staff in the reception area, to STD specialists, to immediate treatment, as well as to laboratory tests.
Among the 633 patients who returned, 579 (91.5%) were considered cured in the first visit and 41 (6.5%) in the second visit, with 620 (98%) of clinical cure, pointing to the fact that SM was effective, as was also reported by Vuylsteke, with a cure rate of 99%. In Senegal, SM was effective in 84.6% of cases. 17, 23 A study conducted in Andhra Pradesh (India) compared SM and laboratorial data for diagnosis and concluded that the simple combination of laboratory tests and syndromic management can increase its effectiveness. presented Chlamydia trachomatis, while 7.3% of the patients were coinfected with chlamydia and gonococcus. These data corroborate the WHO estimates of the incidence and prevalence of STD worldwide. 4 Gonococcal resistance to antimicrobials are increasingly being reported. [25] [26] [27] [28] [29] Despite this fact, we were able to show that SM was effective in a male UDS cohort that was managed as outlined in the Brazilian Ministry of Health STD guidelines, in an STD clinic in Manaus, Amazonas.
The loss of 167 patients due to missed follow-up appointments represented a limitation to this study. However, the two groups -those who returned and those who were lost due to missed follow-up appointments -presented very similar characteristics.
Thus, it could be inferred that the non-return could be associated with non-clinical healing, since the clinical cure was very high among those who returned -91.5% of the cases were cured on the first visit, that is, upon receiving first-line treatment. Resolution of symptoms among all who returned -after the first or second visitwas even greater (98%). Most patients who did not return had a lab diagnosis of gonorrhea, which was associated with a cure rate that was 2.3 times higher than those with other etiological diagnosis.
Therefore, it can be inferred that non-return equals symptoms' resolution, leading to a sense of well-being and no need for further care.
